Cargando…
Pharmacological closure of the patent ductus arteriosus
Pharmacological closure by indomethacin is customary if symptoms of PDA are not controlled adequately with fluid restriction and diuretics. Its use, however, requires a comprehensive clinical assessment of all the vital perinatal factors and a vigilant monitoring of the sick infant. Prophylactic use...
Autores principales: | Mehta, SK, Younoszai, A, Pietz, J, Achanti, BP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232537/ https://www.ncbi.nlm.nih.gov/pubmed/22368623 |
Ejemplares similares
-
Transcatheter closure of patent ductus arteriosus in adults
por: Mori, Yoshiki
Publicado: (2013) -
Recent Strategies and Outcomes of Transcatheter Closure for Patent Ductus Arteriosus
por: Jung, Jo Won
Publicado: (2010) -
Thoracoscopic closure of patent ductus arteriosus in children
por: Kołtowski, P, et al.
Publicado: (2013) -
Flipper coil closure of patent ductus arteriosus
por: Grech, V, et al.
Publicado: (2007) -
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud(®) patent ductus arteriosus device in 268 consecutive cases
por: Maksymenko, Andrii V, et al.
Publicado: (2019)